Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Homologene neighbors
LOC101929148 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KITLG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PECAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL31RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKX2-1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM71A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725022 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00961 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on